Doxazosin [doxazosin]
- Terms
-
Cardura
doxazosin mesilát
doxazosin mesylát
doxazosin monohydrochlorid
doxazosin-mesilát
doxazosin-mesylát
Zoxon
-
1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
Alfamedin
Apo-Doxazosin
Cardular
Cardura
Carduran
Carduran Neo
Diblocin
Doxa-Puren
Doxacor
Doxagamma
Doxamax
Doxatensa
DoxaUro
Doxazomerck
Doxazosin AL
Doxazosin Apogepha
Doxazosin AZU
Doxazosin beta
Doxazosin findusFit
Doxazosin Heumann
Doxazosin Klast
Doxazosin Mesylate
Doxazosin Monohydrochloride
Doxazosin Stada
Doxazosin Von Ct
Doxazosin-ratiopharm
Doxazosin-Wolff
Doxazosina Alter
Doxazosina Cinfa
Doxazosina Combino Pharm
Doxazosina Geminis
Doxazosina Normon
Doxazosina Pharmagenus
Doxazosina Ratiopharm
Doxazosina Ur
Gen-Doxazosin
Jutalar
MTW-Doxazosin
Novo-Doxazosin
Progandol Neo
ratio-Doxazosin
UK-33274
Uriduct
Zoxan
A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
- DUI
- D017292 MeSH Browser
- CUI
- M0026251
- CAS
- Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-
- Previous indexing
- Prazosin/analogs & derivatives (1980-1992)
- History note
- 93; was UK 33274 (NM) 1980-92
- Online note
- use DOXAZOSIN (NM) to search UK 33274 1980-92
- Public note
- 93; UK 33274 was indexed under PRAZOSIN/analogs & derivatives 1980-92
Allowable subheadings
- AD
- administration & dosage 14
- AE
- adverse effects 11
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 8
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 29
- TO
- toxicity
- UR
- urine